Inactive Instrument

Highlights Cell MedX Corp. Other OTC

Equities

CMXC

US15115X1072

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	16/04	CI
Cell MedX Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	17/01	CI
Cell MedX Corp. Reports Earnings Results for the First Quarter Ended August 31, 2023	17/23/17	CI
Cell MedX Corp. Reports Earnings Results for the Full Year Ended May 31, 2023	02/23/02	CI
Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	30/23/30	CI
Cell MedX Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022	19/23/19	CI
Cell MedX Corp. Reports Earnings Results for the First Quarter Ended August 31, 2022	20/23/20	CI
Cell MedX Corp. Reports Earnings Results for the Full Year Ended May 31, 2022	08/23/08	CI
Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	12/22/12	CI
Cell MedX Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2021	13/22/13	CI
Cell MedX Corp. Announces FDA Commences Review of Cell MedX's Premarket Notification and Health Canada Renews Class II Medical Device Licenses for Ebalance(R) Systems	15/21/15	CI
Cell Medx Corp. Reports Earnings Results for the First Quarter Ended August 31, 2021	14/21/14	CI
Cell MedX Corp. Files Premarket Notification with the US Food and Drug Administration	17/21/17	CI
Cell Medx Corp. Reports Earnings Results for the Full Year Ended May 31, 2021	31/21/31	CI
Cell MedX Corp. Reports Earnings Results for the Third Quarter Ended February 28, 2021	09/21/09	CI
Cell Medx Corp. Reports Earnings Results for the Second Quarter Ended November 30, 2020	15/21/15	CI
Cell Medx Corp. Reports Earnings Results for the First Quarter Ended August 31, 2020	16/20/16	CI
Cell MedX Corp Signs an Extension Agreement with Think Ink Marketing Data & Email Services, Inc	24/20/24	CI
Cell Medx Corp. Reports Earnings Results for the Full Year Ended May 31, 2020	16/20/16	CI
Cell Medx Corp.'S Subsidiary Receives Class II Medical Device License from Health Canada	01/20/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cell MedX Corp. Other OTC

Equities

CMXC

US15115X1072

Highlights

Filters